Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.
Market Analysis and Insights: Global Calcium Channel Blocker Market
The global Calcium Channel Blocker market is valued at US$ 74 million in 2019. The market size will reach US$ 83 million by the end of 2026, growing at a CAGR of 1.6% during 2021-2026.
Global Calcium Channel Blocker Scope and Market Size
Calcium Channel Blocker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Calcium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Dihydropyridine
Diltiazem
Verapamil
Others
Segment by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
By Company
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.
Market Analysis and Insights: Global Calcium Channel Blocker Market
The global Calcium Channel Blocker market is valued at US$ 74 million in 2019. The market size will reach US$ 83 million by the end of 2026, growing at a CAGR of 1.6% during 2021-2026.
Global Calcium Channel Blocker Scope and Market Size
Calcium Channel Blocker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Calcium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Dihydropyridine
Diltiazem
Verapamil
Others
Segment by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
By Company
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.